Precision BioSciences Inc (NASDAQ:DTIL)
| 6.97 Delayed Data As of Oct 23 |  +0.12 / +1.75%Today’s Change | 4.46 Today|||52-Week Range 23.67 | -49.82% Year-to-Date |
Latest DTIL News | Press Releases
No recent news for Precision BioSciences Inc.
Today’s Trading
| Previous close | 6.85 |
| Today’s open | 6.80 |
| Day’s range | 6.76 - 6.99 |
| Volume | 6,213 |
| Average volume (3 months) | 653,368 |
| Market cap | $358.6M |
Data as of 4:00pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | -141.25% |
| Earnings growth (this year) | -5.49% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +104.34% |
| P/E ratio | NM |
| Price/Sales | 26.23 |
| Price/Book | 2.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCYCBicycle Therapeutics... | -0.10 | -0.53% |
| PRVLPrevail Therapeutics... | +0.69 | +6.81% |
| RUBYRubius Therapeutics ... | -0.10 | -2.14% |
| CBMGCellular Biomedicine... | +0.02 | +0.11% |
Data as of 4:00pm ET, 10/23/2020
Financials
| Next reporting date | November 17, 2020 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $22.2M |
| Annual profit (last year) | -$92.9M |
| Net profit margin | -417.65% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
